Squadron Capital Management LLC
33 holdingsFiling period: 2026-03-31Current AUM: $279.4Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | RLMD | RELMADA THERAPEUTICS INC | 8.47M | $59.0M | $45.0M | 16.11% | +1.77M | 2026-03-31 |
| 2 | COGT | COGENT BIOSCIENCES INC | 787.5K | $30.3M | $30.7M | 10.97% | +7.5K | 2026-03-31 |
| 3 | KALV | KALVISTA PHARMACEUTICALS INC | 1.30M | $26.2M | $26.2M | 9.37% | +600.1K | 2026-03-31 |
| 4 | KOD | KODIAK SCIENCES INC | 380.0K | $14.5M | $15.8M | 5.66% | +88.3K | 2026-03-31 |
| 5 | ABVX | ABIVAX SA | 130.0K | $14.5M | $16.2M | 5.81% | -15,000 | 2026-03-31 |
| 6 | EWTX | EDGEWISE THERAPEUTICS INC | 350.0K | $11.0M | $13.5M | 4.81% | -- | 2026-03-31 |
| 7 | ZNTL | ZENTALIS PHARMACEUTICALS INC | 4.03M | $9.4M | $19.1M | 6.84% | -- | 2026-03-31 |
| 8 | NKTR | NEKTAR THERAPEUTICS | 125.0K | $9.0M | $8.8M | 3.16% | -- | 2026-03-31 |
| 9 | ANL | ADLAI NORTYE LTD | 1.27M | $8.8M | $16.4M | 5.89% | -- | 2026-03-31 |
| 10 | RLAY | RELAY THERAPEUTICS INC | 822.5K | $8.2M | $15.5M | 5.54% | -- | 2026-03-31 |
| 11 | MAZE | MAZE THERAPEUTICS INC | 257.5K | $7.7M | $6.9M | 2.48% | -232,500 | 2026-03-31 |
| 12 | IDYA | IDEAYA BIOSCIENCES INC | 224.3K | $7.5M | $8.0M | 2.85% | -- | 2026-03-31 |
| 13 | SCYX | SCYNEXIS INC | 7.61M | $7.0M | $4.6M | 1.65% | -- | 2026-03-31 |
| 14 | CCCC | C4 THERAPEUTICS INC | 2.25M | $5.9M | $7.8M | 2.80% | -- | 2026-03-31 |
| 15 | IKT | INHIBIKASE THERAPEUTICS INC | 3.50M | $5.9M | $7.6M | 2.73% | -725,000 | 2026-03-31 |
| 16 | PALI | PALISADE BIO INC | 3.00M | $5.3M | $5.7M | 2.03% | -1,500,000 | 2026-03-31 |
| 17 | EPRX | EUPRAXIA PHARMACEUTICALS INC | 680.0K | $4.9M | $4.4M | 1.56% | +180.0K | 2026-03-31 |
| 18 | — | GH RESEARCH PLC | 325.0K | $4.6M | $4.6M | 1.64% | +10.0K | 2026-03-31 |
| 19 | KPTI | KARYOPHARM THERAPEUTICS INC | 750.0K | $4.2M | $1.4M | 0.52% | -- | 2026-03-31 |
| 20 | PMN | PROMIS NEUROSCIENCES INC | 325.0K | $4.1M | $4.5M | 1.60% | -- | 2026-03-31 |
| 21 | LPCN | LIPOCINE INC NEW | 450.0K | $3.6M | $954K | 0.34% | -80,000 | 2026-03-31 |
| 22 | IVA | INVENTIVA SA | 535.0K | $3.0M | $2.4M | 0.86% | +235.0K | 2026-03-31 |
| 23 | ALXO | ALX ONCOLOGY HLDGS INC | 1.46M | $2.9M | $2.8M | 1.01% | -- | 2026-03-31 |
| 24 | CNTX | CONTEXT THERAPEUTICS INC | 1.10M | $2.9M | $659K | 0.24% | -- | 2026-03-31 |
| 25 | NXTC | NEXTCURE INC | 265.0K | $2.8M | $1.1M | 0.39% | +28.0K | 2026-03-31 |
← Scroll →
Page 1 of 2